Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05215314 · ClinicalTrials.gov registry record · NA

Brain and Meditation (BAM) Study

A NA study of Stress and Behavior, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05215314: Completed NA study of Stress and Behavior, sponsored by University of Wisconsin, Madison.

NCT05215314 is a NA study of Stress and Behavior that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 150 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05215314, a NA study of Stress and Behavior, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized controlled trial to test the impact of an app-based meditation program on perceived stress and behavioral correlates of stress with known neurobiological correlates. Healthy adult participants between the ages of 25-65 will be enrolled in the study for about 4-5 months.

Primary Outcome

PSS is a 10-item survey scored on a 5 point likert scale from 0 = never to 4 = very often, for a total possible range of scores from 0-40 where higher scores indicate higher perceived stress.

Conditions Studied

Interventions

  • BEHAVIORAL mHealth Meditation

Study Locations (1)

Wisconsin

  • Center for Healthy Minds - Madison

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-04-13
Est. Completion 2024-01-09
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT05215314 record still lists

NCT05215314 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 152 other Stress trials with a reported enrollment target (81% lower).

The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which mHealth Meditation is the first listed.

NCT05215314 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05215314 about?

NCT05215314 is a clinical study titled "Brain and Meditation (BAM) Study". This study is a randomized controlled trial to test the impact of an app-based meditation program on perceived stress and behavioral correlates of stress with known neurobiological correlates. Healthy adult participants between the ages of 25-65 will be enrolled in the study for about 4-5 months.

What is the current status of trial NCT05215314?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2022-04-13. Estimated completion is 2024-01-09.

What conditions does trial NCT05215314 study?

This clinical trial studies the following conditions: Stress, Behavior.

What interventions are being tested in trial NCT05215314?

The interventions under investigation include: mHealth Meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05215314?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05215314 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05215314's enrollment target sits among peer trials

150 43rd of 152 higher than 108 of 152 other Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05215314, the US trial registry maintained by the National Library of Medicine. NCT05215314 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.